A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
Status:
Unknown status
Trial end date:
2019-07-31
Target enrollment:
Participant gender:
Summary
This is a proof-of-concept trial to compare 18F-FDG-PET/CT with NETSPOT (68Ga-DOTA-TATE), a
commercially available radiotracer packet that utilizes 68Ga to image SSTR-specific tissue.